Methylphenidate versus placebo for fatigue in patients with advanced cancer: the MePFAC randomised controlled trial · List of supplementary material
List of supplementary material
CC BY 4.0 · National Institute for Health and Care Research · approximately 1 min read
-
Methylphenidate versus placebo for fatigue in advanced cancer Protocol v14.0 17 January 2023
-
Statistical analysis plan v7 31 July 2023
-
Predictors of missingness
-
Kaplan–Meier survival curves
-
Changes in response to COVID
-
Research Active Hospices Report
-
EAPC Conference Abstract
Supplementary material can be found on the NIHR Journals Library report page (https://doi.org/10.3310/GJPS6321).
Supplementary material has been provided by the authors to support the report and any files provided at submission will have been seen by peer reviewers, but not extensively reviewed. Any supplementary material provided at a later stage in the process may not have been peer reviewed.
Attribution. Patrick Stone; Ollie Minton; Alison Richardson; Peter Buckle; Zinat E Enayat; Louise Marston et al. (2025). Methylphenidate versus placebo for fatigue in patients with advanced cancer: the MePFAC randomised controlled trial. National Institute for Health and Care Research. Copyright © 2025 Stone et al. Licensed under CC BY 4.0. NCBI Bookshelf NBK616759. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.